The Pines At Poughkeepsie Ctr For Nursing & Rehab | |
100 Franklin Street, Poughkeepsie, New York 12601 | |
(845) 454-4100 | |
Name | The Pines At Poughkeepsie Ctr For Nursing & Rehab |
---|---|
Location | 100 Franklin Street, Poughkeepsie, New York |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 200 |
Occupancy Rate | 79.95% |
Medicare ID (CCN) | 335440 |
Legal Business Name | Poughkeepsie Crossings Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1548330624 |
Organization Name | EDEN PARK HEALTH SERVICES, INC. |
Doing Business As | EDEN PARK HEALTH CARE CENTER |
Address | 100 Franklin St, Poughkeepsie, NY 12601 |
Phone Number | 845-454-4100 |
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
In support of disaster relief efforts in Japan following the recent earthquake and tsunami, Ovid and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, are providing free online access to emergency, disaster, trauma, and radiation contamination resources to Japanese hospitals and healthcare institutions affected by the disasters via the Wolters Kluwer Health Emergency Resources Portal.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
› Verified 2 days ago
NPI Number | 1952517815 |
Organization Name | POUGHKEEPSIE CROSSINGS LLC |
Address | 100 Franklin Street, Poughkeepsie, NY 12601 |
Phone Number | 845-454-4100 |
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
In support of disaster relief efforts in Japan following the recent earthquake and tsunami, Ovid and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, are providing free online access to emergency, disaster, trauma, and radiation contamination resources to Japanese hospitals and healthcare institutions affected by the disasters via the Wolters Kluwer Health Emergency Resources Portal.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
In support of disaster relief efforts in Japan following the recent earthquake and tsunami, Ovid and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, are providing free online access to emergency, disaster, trauma, and radiation contamination resources to Japanese hospitals and healthcare institutions affected by the disasters via the Wolters Kluwer Health Emergency Resources Portal.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.26 | 14.46 |
Percentage of long-stay residents who lose too much weight | 9.65 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.64 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.55 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.19 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.79 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.18 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.66 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.94 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 17.57 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.39 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.52 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.19 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.2 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 4.65 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.65 | 95.98 |
Percentage of short-stay residents who made improvements in function | 91.82 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.47 | 82.93 |
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
In support of disaster relief efforts in Japan following the recent earthquake and tsunami, Ovid and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, are providing free online access to emergency, disaster, trauma, and radiation contamination resources to Japanese hospitals and healthcare institutions affected by the disasters via the Wolters Kluwer Health Emergency Resources Portal.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a 'reset' of their brain activity.
Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.
Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.
› Verified 2 days ago
The Pines At Poughkeepsie Ctr For Nursing & Rehab Location: 100 Franklin Street, Poughkeepsie, New York 12601 Phone: (845) 454-4100 | |
Lutheran Center At Poughkeepsie Inc Location: 965 Dutchess Turnpike, Poughkeepsie, New York 12603 Phone: (845) 486-9494 | |
The Grand Rehabilitation And Nrsg At River Valley Location: 140 Main Street, Poughkeepsie, New York 12601 Phone: (845) 454-7600 |